Hey, good to see you, Sam. Actually, really good news when it comes to Tempest AI from the standpoint of FDA clearance of their in vitro drug discovery program. Uh the stock did trade quite a bit to the upside around $97 early today.It's selling off as we move through the close of the day. But nonetheless, uh if you take a look at the price action in this name over the last year basis, it's up over 180%. And it's really uh a healthcare technology company that's uh that's focused on life science technologies ...